Leonovus Inc. (TSXV:LTV) (the “
Company” or
“
Leonovus”), is pleased to announce that it has
filed and been receipted for a preliminary short form prospectus
with the securities regulatory authorities in all provinces of
Canada (except Québec) in connection with a marketed public
offering (the “
Offering”) of units of the Company
(“
Units”) priced in the context of the market, at
an indicative price of $0.68 per Unit, for gross proceeds of up to
$4,000,000. The Offering is being led by Mackie Research Capital
Corporation as lead agent and sole bookrunner (the “
Lead
Agent”), on behalf of a syndicate of agents, including
Canaccord Genuity Corp. (collectively with the Lead Agent, the
“
Agents”).
Each Unit will consist of one common share of
the Company (“Common Share”) and one Common Share
purchase warrant (a “Warrant”). Each Warrant shall
entitle the holder thereof to purchase one Common Share (a
“Warrant Share”) at an indicative exercise price
of $0.84, to be determined in the context of the market for an
indicative period of 36 months following closing of the
Offering.
The final pricing of each Unit, the exercise
price of each Warrant, and the term of each Warrant will be
determined in the context of the market prior to the filing of the
final short form prospects in respect of the Offering.
The Company has granted the Agents an option
(the “Over-Allotment Option”) to cover
over-allotments and for market stabilization purposes, exercisable
in whole or in part at the sole discretion of the Agent, at any
time up to 30 days from the closing of the Offering, to increase
the size of the Offering by up to 15% of the number of Units
(and/or the components thereof) sold pursuant to the Offering, on
the same terms and conditions of the Offering.
The net proceeds raised under the Offering will
be used for product development and management, sales and
marketing, operating expenses, and general and administrative
expenses as well as for working capital requirements and other
general corporate purposes.
The closing of the Offering is currently
expected to be on or about the week of April 26, 2021, or on such
date as the Lead Agent and the Company may agree upon, and is
subject to certain conditions including, but not limited to the
execution of an agency agreement and the receipt of all necessary
regulatory approvals including the approval of the TSX Venture
Exchange (the “Exchange”).
The Company will use commercially reasonable
efforts to list the Common Shares, the Warrants and the Warrant
Shares on the Exchange, subject to the Company fulfilling all of
the listing requirements of the Exchange.
The Units are to be sold on a "best efforts"
basis through the Agents by way of short form prospectus to be
filed in each of the provinces of Canada (except Québec) and in
other jurisdictions outside of Canada and the United States on an
exempt basis in accordance with applicable securities laws. The
securities described in this press release have not been and will
not be registered under the United States Securities Act of 1933,
as amended (“U.S. Securities Act”) or any state
securities laws. Accordingly, the securities may not be offered or
sold in the United States (as such term is defined in Regulation S
under the U.S. Securities Act) or to, or for the account or benefit
of, a U.S. person (as such term is defined in Regulation S under
the U.S. Securities Act) except pursuant to transactions exempt
from registration under the U.S. Securities Act and under the
securities laws of any applicable state. This press release does
not constitute an offer to sell or a solicitation of an offer to
buy any of these securities in the United States. Any public
offering of securities in the United States must be made by means
of a prospectus containing detailed information about the company
and management, as well as financial statements.
About Leonovus
Leonovus is a secure data management software
company. The Leonovus suite of data management tools offer an
organization what it needs for a complete end-to-end data-centric
solution. This solution can stand on its own, or it can easily
integrate with the organization's zero-trust strategy and
architecture. It takes seamless advantage of the organization's
existing storage infrastructure and network architecture, working
on-premises, in the cloud, or both. It extends the data-centric
controls across the entire architecture, including cloud resources.
And it supplies these cybersecurity capabilities for the full
lifespan of the data and beyond.
The flexible and straightforward solution does
not require changes in the method of data use. Applications,
services, and users all interact with the data the same way they
always have. The system ensures the right users get access to the
correct data at the right time, but securely.
In addition to working with existing systems,
the Leonovus solution aids in the organization's digital
transformation by enabling ultramodern data concepts necessary for
the data-driven world. These capabilities are included in an
automated solution requiring little operations effort and no new
skills or expertise needed.
The main elements of the Leonovus Unified Smart
Data Management suite are:
Data Discovery - classification and understanding of your
existing data sets.Smart Filer - transparent file-based data
controls for cost, flexibility, and scalability.Vault - multi-cloud
data management for data lifespan.Data View Gateways - controlled
repository internal/external data sharing.Smart Secure Data Lake -
a multi-sourced context-rich repository for advanced
analytics.Consolidata - multi-sourced data collation and
aggregation for near real-time insights.XVault – protocol
independent, ultra-secure remote data sharing solution; coming
soon.
Each is available independently or together as a
comprehensive solution set. To learn more, please
visit www.leonovus.com.
For More Information, please contact:George
PretliChief Financial Officer
+1.613.319.3540gpretli@leonovus.com
Caution regarding forward-looking
information
This press release contains forward-looking
statements and information, which may involve risks and
uncertainties, including in relation to pricing and terms of the
Offering, receipt of regulatory and Exchange approval of the
Offering, the issuance of a receipt for the final short form
prospectus, the use of proceeds from the Offering, and the closing
of the Offering and timing thereof. The results or events predicted
in these statements may differ materially from actual results or
events. Factors that might cause a difference include, but are not
limited to, competitive developments, risks associated with
Leonovus' growth, the state of the financial markets, regulatory
risks and other factors. There can be no assurance or guarantees
that any statements of forward-looking information contained in
this release will prove to be accurate. Actual results and future
events could differ materially from those anticipated in such
statements. These and all subsequent written and oral statements
containing forward-looking information are based on the estimates
and opinions of management on the dates they are made and expressly
qualified in their entirety by this notice. Unless otherwise
required by applicable securities laws, Leonovus disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise. Readers should not place undue reliance on any
statements of forward-looking information that speak only as of the
date of this release. Further information on Leonovus' public
filings, including its most recent audited consolidated financial
statements, are available at www.sedar.com.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
LeoNovus (TSXV:LTV)
Historical Stock Chart
From Dec 2024 to Jan 2025
LeoNovus (TSXV:LTV)
Historical Stock Chart
From Jan 2024 to Jan 2025